Literature DB >> 16372321

Age-related morphological changes in skeletal muscle cells of acid alpha-glucosidase knockout mice.

Reinout P Hesselink1, Gert Schaart, Anton J M Wagenmakers, Maarten R Drost, Ger J van der Vusse.   

Abstract

Glycogen storage disease type II (GSDII), caused by a genetic defect in acid alpha-glucosidase (AGLU), leads to a decline in muscle contractility caused by both muscle wasting and a decrease in muscle quality, i.e., force generated per unit muscle mass. A previous study has shown that loss of muscle mass can only explain one-third of the decrease in contractile performance. Here we report on changes in the intramyocellular structural organization in a mouse knockout model (AGLU(-/-) mice) as a possible cause for the decline in muscle quality. Swollen, glycogen-filled lysosomes and centrally localized cores with cellular debris partially contribute to the decline in muscle quality. Altered localization and deposition of cytoskeletal proteins desmin and titin may reflect adaptive mechanisms at the age of 13 months, but a decline in quality at 20 months of age. The early deposition of lipofuscin in AGLU-deficient myocytes (13 months) is most likely a reflection of enhanced oxidative stress, which may also affect muscle quality. These collective findings, on the one hand, may explain the decrease in tissue quality and, on the other, may represent markers for efficacy of therapeutic interventions to restore muscle function in patients suffering from GSDII.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372321     DOI: 10.1002/mus.20482

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  9 in total

Review 1.  Role of autophagy in the pathogenesis of Pompe disease.

Authors:  N Raben; A Roberts; P H Plotz
Journal:  Acta Myol       Date:  2007-07

Review 2.  Acid alpha-glucosidase deficiency (Pompe disease).

Authors:  Tokiko Fukuda; Ashley Roberts; Paul H Plotz; Nina Raben
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

3.  Impaired organization and function of myofilaments in single muscle fibers from a mouse model of Pompe disease.

Authors:  Sengen Xu; Mikhail Galperin; Gary Melvin; Robert Horowits; Nina Raben; Paul Plotz; Leepo Yu
Journal:  J Appl Physiol (1985)       Date:  2010-03-11

4.  Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease.

Authors:  Tokiko Fukuda; Meghan Ahearn; Ashley Roberts; Robert J Mattaliano; Kristien Zaal; Evelyn Ralston; Paul H Plotz; Nina Raben
Journal:  Mol Ther       Date:  2006-09-27       Impact factor: 11.454

Review 5.  Cardiac aging: from molecular mechanisms to significance in human health and disease.

Authors:  Dao-Fu Dai; Tony Chen; Simon C Johnson; Hazel Szeto; Peter S Rabinovitch
Journal:  Antioxid Redox Signal       Date:  2012-04-03       Impact factor: 8.401

6.  A study of glycogen storage disease with 99Tcm-MIBI gated myocardial perfusion imaging.

Authors:  L G Wei; J Q Gao; X M Liu; J M Huang; X Z Li
Journal:  Ir J Med Sci       Date:  2013-04-25       Impact factor: 1.568

7.  Altered activation of the tibialis anterior in individuals with Pompe disease: Implications for motor unit dysfunction.

Authors:  Manuela Corti; Barbara K Smith; Darin J Falk; Lee Ann Lawson; David D Fuller; S H Subramony; Barry J Byrne; Evangelos A Christou
Journal:  Muscle Nerve       Date:  2015-04-24       Impact factor: 3.217

8.  Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease.

Authors:  Jason Wang; Chris J Zhou; Alastair Khodabukus; Sabrina Tran; Sang-Oh Han; Aaron L Carlson; Lauran Madden; Priya S Kishnani; Dwight D Koeberl; Nenad Bursac
Journal:  Commun Biol       Date:  2021-05-05

9.  Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II).

Authors:  Lydie Lagalice; Julien Pichon; Eliot Gougeon; Salwa Soussi; Johan Deniaud; Mireille Ledevin; Virginie Maurier; Isabelle Leroux; Sylvie Durand; Carine Ciron; Francesca Franzoso; Laurence Dubreil; Thibaut Larcher; Karl Rouger; Marie-Anne Colle
Journal:  Acta Neuropathol Commun       Date:  2018-10-31       Impact factor: 7.801

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.